regulatory
confidence high
sentiment positive
materiality 0.60
Pieris Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
PALVELLA THERAPEUTICS, INC.
- Received Nasdaq letter on May 7, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price above $1.00 for 10 consecutive business days (April 23 to May 6, 2024).
- Matter is now closed; no further action required by the company.
- Stock symbol: PIRS, traded on Nasdaq Capital Market.